A PTV-loaded nanocarrier was developed to trigger the apoptosis of glioblastoma multiforme cells by reducing the mRNA levels of NFKB, IL6, BIRC1, and BIRC5 (Psc et al., 2021). The gene discussed is BIRC5; the disease is glioblastoma.